|
|
|
|
||
Re: Not Entertaining Buyout Offers Hi frogs, do your valuation numbers include Ingrezza approval, launch, and sales for "Japan and select Asian countries"? https://clinicaltrials.gov/ct2/show/NCT03176771?term=MT-5199-J02&rank=1 https://www.mt-pharma.co.jp/e/release/nr/2017/pdf/e_MTPC170727.pdf |
return to message board, top of board |